Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced the ...
Healthcare products company unveils new brand identity and introduces Silkura, a revolutionary silicone-based ostomy pouch ...
Ruling preserves current contracted royalty rates and rejects Tesaro’s request for any royalty reduction; Trial to adjudicate Anaptys’ contract claims and right to seek revers ...
President Trump on April 18 issued an Executive Order directing the U.S. Department of Health and Human Services to accelerate access to treatments for patients with serious mental illness, including ...
MINNEAPOLIS, April 24, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the ...
All product details are based on provided official Performance Lab materials and should be verified on the official website before any purchasing decision. These statements have not been evaluated by ...
Paraxanthine is the metabolite the human liver produces when it breaks down caffeine. Recent peer-reviewed research identifies paraxanthine as the molecule responsible for much of caffeine's cognitive ...
1 000 millions d’euros d’obligations à taux fixe, échéance mai 2029, portant intérêt au taux annuel de 3,000% 650 millions d’euros d’obligations à taux fixe, échéance mai 2033, portant intérêt au tau ...
Annual Shareholder Meeting to be held at 10:00 am PT on June 17, 2026 - IRVINE, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) ...
The general shareholders meeting of 24 April 2026 has approved the annual accounts as at 31 December 2025, including the distribution of a gross dividend of € 1.08 per share. The dividend will be paya ...
L’assemblée générale des actionnaires du 24 avril 2026 a approuvé les comptes annuels relatifs à l’exercice social clôturé le 31 décembre 2025, en ce compris la distribution d’un dividende brut de € 1 ...
KFSH’s integrated framework connects medical genomics, an internationally accredited precision medicine laboratory, computational sciences, and translational research, creating a system where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results